Metraipolis › archive › dc_da28e22ea480

Immune Checkpoint Inhibitor-Associated Myocarditis: Risk, Diagnosis, and Clinical Impact — Europe PMC PMID:41598751

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41598751
DOI
10.3390/jcm15020814
License (as archived)
solo-consultazione
Archived
2026-11-06T17:00:23.894Z
SHA-256 of the archived text
11f9b9a9758b6008637e77a83ac992583f83e7d1d6873c85851282bdaf46e9e5
Stable URL of this page
https://metraipolis.com/documento/dc_da28e22ea480

How to cite

Immune Checkpoint Inhibitor-Associated Myocarditis: Risk, Diagnosis, and Clinical Impact — Europe PMC PMID:41598751 — Europe PMC (en), https://europepmc.org/article/MED/41598751 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da28e22ea480 (Metraipolis archive dc_da28e22ea480, sha256 11f9b9a9758b6008637e77a83ac992583f83e7d1d6873c85851282bdaf46e9e5)
BibTeX
@misc{dcda28e22ea480,
  title = {Immune Checkpoint Inhibitor-Associated Myocarditis: Risk, Diagnosis, and Clinical Impact — Europe PMC PMID:41598751},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598751},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da28e22ea480; sha256 11f9b9a9758b6008637e77a83ac992583f83e7d1d6873c85851282bdaf46e9e5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598751. Agents can read the archived copy with the MCP tool read_document.